Wolverine Asset Management LLC Amgen Inc Call Options Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $3.19 Million - $3.48 Million	10,300 Added 54.5%	29,200 $9.41 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $867,075 - $1.05 Million	3,300 Added 21.15%	18,900 $5.91 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $5.92 Million - $7.14 Million	-22,000 Reduced 58.51%	15,600 $4.44 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 0.53%	37,600 $10.8 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $2.14 Million - $2.66 Million	-9,800 Reduced 20.59%	37,800 $10.2 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $171,416 - $202,696	-800 Reduced 1.65%	47,600 $10.6 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $9.87 Million - $12 Million	43,700 Added 929.79%	48,400 $11.7 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $1.08 Million - $1.37 Million	4,700 New	4,700 $1.23 Million
Q2 2017 Aug 14, 2017	BUY	N/A	4,500	4,500 $775,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.